Abstract:Abstract Background Recently, carbon quantum dots (CQDs) have been widely used in various fields, especially in the diagnosis and therapy of neurological disorders, due to their excellent prospects. However, the associated inevitable exposure of CQDs to the environment and the public could have serious severe consequences limiting their safe application and sustainable development. Results In this study, we found that intranasal treatment of 5 mg/kg BW (20 µL/nose of 0.5 mg/mL) CQDs affected the distribution of multiple metabolites and associated pathways in the brain of mice through the airflow-assisted desorption electrospray ionization mass spectrometry imaging (AFADESI-MSI) technique, which proved effective in discovery has proven to be significantly alerted and research into tissue-specific toxic biomarkers and molecular toxicity analysis. The neurotoxic biomarkers of CQDs identified by MSI analysis mainly contained aminos, lipids and lipid-like molecules which are involved in arginine and proline metabolism, biosynthesis of unsaturated fatty acids, and glutamine and glutamate metabolism, etc. as well as related metabolic enzymes. The levels or expressions of these metabolites and enzymes changed by CQDs in different brain regions would induce neuroinflammation, organelle damage, oxidative stress and multiple programmed cell deaths (PCDs), leading to neurodegeneration, such as Parkinson’s disease-like symptoms. This study enlightened risk assessments and interventions of QD-type or carbon-based nanoparticles on the nervous system based on toxic biomarkers regarding region-specific profiling of altered metabolic signatures. Conclusion These findings provide information to advance knowledge of neurotoxic effects of CQDs and guide their further safety evaluation.

Quantum dots protect against MPP+-induced neurotoxicity in a cell model of Parkinson’s disease through autophagy induction

The Role of Elevated Autophagy on the Synaptic Plasticity Impairment Caused by CdSe/ZnS Quantum Dots.

Modulating SQSTM1/p62-dependent selective autophagy of neurons by activating Nrf2 with multifunctional nanoparticles to eliminate α-synuclein aggregates and boost therapy of Parkinson’s disease

Modulating SQSTM/p62-dependent selective autophagy of neurons by activating Nrf2 with multifunctional nanoparticles to eliminate -synuclein aggregates and boost therapy of Parkinson's disease

Brain-targeted Gene Delivery of ZnO Quantum Dots Nanoplatform for the Treatment of Parkinson Disease

Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity

Inhibition of autophagy overcomes the nanotoxicity elicited by cadmium-based quantum dots.

Research advances on potential neurotoxicity of quantum dots

Putative Adverse Outcome Pathway for Parkinson's Disease-like Symptoms Induced by Silicon Quantum Dots based on In Vivo/ Vitro Approaches

Putative Adverse Outcome Pathway for Parkinson’s Disease-like Symptoms Induced by Silicon Quantum Dots Based on in Vivo/Vitro Approaches

Dioscin-Mediated Autophagy Alleviates MPP+-Induced Neuronal Degeneration: An In Vitro Parkinson’s Disease Model

Pyrroloquinoline Quinone-Conferred Neuroprotection in Rotenone Models of Parkinson'S Disease

Protection Against Neurotoxicity by an Autophagic Mechanism.

Potential Autophagy Enhancers Attenuate Rotenone-Induced Toxicity in Sh-Sy5y

Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer’s Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation

Partial protection of N-acetylcysteine against MPA-capped CdTe quantum dot-induced neurotoxicity in rat primary cultured hippocampal neurons

Resveratrol-Activated Ampk/Sirt1/Autophagy in Cellular Models of Parkinson'S Disease

The Discovery of Regional Neurotoxicity-Associated Metabolic Alterations Induced by Carbon Quantum Dots in Brain of Mice Using a Spatial Metabolomics Analysis

Graphene Quantum Dots Induce Autophagy And Reveal Protection Against Hydrogen Peroxide-Induced Oxidative Stress Injury

An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity.

Facilitating Pro-survival Mitophagy for Alleviating Parkinson's Disease Via Sequence-Targeted Lycopene Nanodots.